<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1999
-------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________________ to _________________
Commission file number 0-13591
-------
PROVIDENT AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)
Pennsylvania 23-2214195
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2500 DeKalb Pike, Norristown, Pennsylvania 19401
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (610) 279-2500
Former name, former address and former fiscal year, if changed since last
report: N/A
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
---
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date: 12,337,530 shares of common
stock, par value $.10, outstanding as of August 6, 1999.
Page 1 of 31 Pages
<PAGE>
PROVIDENT AMERICAN CORPORATION
"The filing, on August 16, 1999, of the Company's Form 10-Q for the quarter
ended June 30, 1999, was inadvertently filed by the Company's financial printer,
in that it was not the final version. Accordingly, this Form 10-Q/A represents
the final correct version and replaces in its entirety the Form 10-Q previously
filed."
INDEX
Page No.
Part I. FINANCIAL INFORMATION --------
Item 1. Condensed Financial Statements
Consolidated Statements of Operations 3
Consolidated Balance Sheets 4-5
Consolidated Statements of Changes in Stockholders' Equity 6
Consolidated Statements of Cash Flows 7-8
Notes to Condensed Consolidated Financial Statements 9-19
Item 2. Management's Discussion and Analysis of Results
of Operations and Financial Condition 20-28
Recent Sales of Unregistered Securities 28
Part II. OTHER INFORMATION
Items 1- 5 30
Reports on Form 8-K 30
SIGNATURES 31
Exhibit 11
Exhibit 27
Page 2 of 31 Pages
<PAGE>
PART I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Provident American Corporation and Subsidiaries
Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share data)
<TABLE>
<CAPTION>
3 Months Ended June 30, 6 Months Ended June 30,
1999 1998 1999 1998
---- ---- ---- ----
<S> <C> <C> <C> <C>
Revenue:
Premium: Accident and health, gross $ 23,824 $ 27,195 $ 49,296 $ 55,863
Life and annuity, gross 1,675 2,099 3,371 4,576
---------- --------- --------- ---------
Total gross premium 25,499 29,294 52,667 60,439
---------- --------- --------- ---------
Accident and health reinsurance ceded 22,807 13,106 47,796 24,805
Life and annuity reinsurance ceded 351 25 817 74
---------- --------- --------- ---------
Total reinsurance ceded 23,158 13,131 48,613 24,879
---------- --------- --------- ---------
Net premium 2,341 16,163 4,054 35,560
Net investment income 689 987 1,613 1,906
Realized gains (losses) on investments (65) 13 (65) 13
Realized gain on the sale of subsidiary 0 0 1,500 4,000
Other revenue 221 5 517 128
---------- --------- --------- ---------
Total revenue 3,186 17,168 7,619 41,607
---------- --------- --------- ---------
Benefits and expenses:
Death and other policy benefits:
Life 1,340 1,372 2,730 2,485
Accident and health, net of reinsurance 2,167 9,781 2,572 21,876
Annuity contracts and other considerations 228 83 98 171
Increase (decrease) in liability for future policy benefits (178) (522) 299 (524)
Commissions, net of ceding allowance and deferred acquisition 447 2,586 704 5,323
costs
Other operating expenses, net of ceding allowance
and deferred acquisition costs 5,819 5,249 8,885 10,359
Interactive sales and marketing expense 4,690 486 6,435 611
Amortization of deferred policy acquisition costs 133 307 252 540
Depreciation and amortization of goodwill 399 209 721 435
---------- --------- --------- ---------
Total benefits and expenses 15,045 19,551 22,696 41,276
---------- --------- --------- ---------
Income (loss) before taxes and minority interest (11,859) (2,382) (15,077) 331
Provision (benefit) for income taxes:
Current 3 (38) 18 3
Deferred 0 0 0 0
---------- --------- --------- ---------
Total income taxes 3 (38) 18 3
---------- --------- --------- ---------
Net income (loss) before minority interest (11,862) 0 (15,095) 0
Minority interest in net loss of subsidiary 1,358 0 1,724 0
---------- --------- --------- ---------
Net income (loss) (10,504) (2,344) (13,371) 328
---------- --------- --------- ---------
Dividends on preferred stock 35 37 69 74
---------- --------- --------- ---------
Net income (loss) applicable to common stock (10,539) (2,381) (13,440) 254
========== ========= ========= =========
Income (loss) per share of common stock
Basic $ (0.88) $ (0.20) $ (1.14) $ 0.02
========== ========= ========= =========
Diluted $ (0.88) $ (0.20) $ (1.14) $ 0.02
========== ========= ========= =========
Common shares and equivalents used in computing income (loss) per
share
Basic 12,039 11,990 11,797 11,699
Diluted 12,039 11,990 11,797 11,773
</TABLE>
See notes to consolidated financial statements.
Page 3 of 31 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Balance Sheets
(Dollars in thousands, except preferred and common stock data)
<TABLE>
<CAPTION>
UNAUDITED
June 30, 1999 December 31, 1998
------------- -----------------
<S> <C> <C>
Assets
Investments:
Securities available for sale $ 24,790 $ 31,880
Policy loans 547 560
Other invested assets 521 529
--------- ----------
Total Investments 25,858 32,969
Cash and cash equivalents 12,534 26,185
Amounts due from third party administrator 0 6,849
Premiums due and uncollected 976 1,167
Amounts due from reinsurers 36,687 22,222
Loans receivable from officer, director and stockholder 642 1,328
Accrued investment income 344 420
Prepaid interactive marketing expense 9,599 11,655
Property and equipment, less accumulated depreciation of $3,764 and $3,099 8,482 7,950
Unamortized deferred policy acquisition costs 2,205 2,106
Other assets 3,196 3,838
--------- ----------
Total Assets $ 100,523 $ 116,689
</TABLE>
Continued on next page.
See notes to consolidated financial statements.
Page 4 of 31 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Balance Sheets (Continued)
(Dollars in thousands, except preferred and common stock data)
<TABLE>
<CAPTION>
UNAUDITED
June 30, 1999 December 31, 1998
------------- -----------------
<S> <C> <C>
Liabilities and Stockholders' Equity
Liabilities:
Future policy benefits:
Life $ 43,009 $ 42,546
Annuity and other 4,467 4,871
Policy claims 27,113 42,481
Premiums received in advance and unearned 0 335
Amounts due to reinsurers 307 501
Accounts payable 960 2,107
Accrued commissions and expenses 3,210 2,384
Loans payable 0 3,865
Federal income taxes 673 1,222
Ceding commission liability 5,300 5,000
Other liabilities 2,061 1,945
--------- ---------
Total Liabilities 87,100 107,257
Commitments and Contingencies:
Minority Interest in HealthAxis.com, Inc.:
Minority interest in HealthAxis.com, Inc. common stock 875 1,132
HealthAxis.com, Inc. preferred stock - Cumulative preferred stock, par
value $1: authorized 5,000,000 shares:
Series B , issued 625,529 2,804 2,805
Series C, issued 1,526,412 and 0 7,845 0
Stockholders' Equity:
Preferred stock, par value $1: authorized 20,000,000 shares:
Series A Cumulative convertible, issued 550,000 and 556,600 550 557
Series B Cumulative convertible, none issued 0 0
Common stock, par value $.10: authorized 50,000,000, issued 12,204,728 and
11,488,911 1,220 1,149
Common stock, Class A, par value $.10: authorized 20,000,000, none issued 0 0
Additional paid-in capital 37,341 27,002
Accumulated other comprehensive income 107 666
Retained earnings (37,319) (23,879)
--------- ---------
Total Stockholders' Equity 1,899 5,495
--------- ---------
Total Liabilities and Stockholders' Equity $ 100,523 $ 116,689
</TABLE>
See notes to condensed financial statements.
Page 5 of 31 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Statements of Changes in Stockholders' Equity (Unaudited)
(in thousands)
<TABLE>
<CAPTION>
Preferred Stock Common Stock Additional Retained
Paid-In Earnings
Shares Amount Shares Amount Capital (Deficit)
------ ------ ------ ------ ------- ---------
<S> <C> <C> <C> <C> <C> <C>
BALANCE, DECEMBER 31, 1998 557 $ 557 11,489 $ 1,149 $ 27,002 $ (23,879)
Comprehensive income:
Net income (loss) (13,371)
Other comprehensive income (loss)
Comprehensive income
Issuance of common stock 25 2 267
Stock options and warrants exercised 684 68 4,386
Increase in net assets in HealthAxis.com, Inc. 5,680
Conversion of Preferred Stock (7) (7) 7 1 6
Cash dividends declared on preferred stock (69)
----- ----- ------- ------- -------- ---------
BALANCE, JUNE 30, 1999 550 $ 550 12,205 $ 1,220 $ 37,341 $ (37,319)
===== ===== ======= ======= ======== =========
Accumulated
Other
Comprehensive
Income (Loss) Total
------------- -----
$ 666 $ 5,495
BALANCE, DECEMBER 31, 1998
Comprehensive income: (13,371)
Net income (loss) (559) (559)
Other comprehensive income (loss) ----- -------
(13,930)
Comprehensive income -------
269
Issuance of common stock 4,454
Stock options and warrants exercised 5,680
Increase in net assets in HealthAxis.com, Inc.
0
Conversion of Preferred Stock (69)
Cash dividends declared on preferred stock ----- --------
$ 107 $ 1,899
BALANCE, JUNE 30, 1999 ====== =======
</TABLE>
See notes to consolidated financial statements.
Page 6 of 31 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Unaudited)
(Dollars in thousands)
<TABLE>
<CAPTION>
6 Months Ended June 30,
1999 1998
------ ------
<S> <C> <C>
Cash flows from operating activities
Net income (loss) $ (13,371) $ 328
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Depreciation and amortization 5,708 441
Net realized (gain) on sale of subsidiary (1,500) (13)
Minority interest in net loss (1,724) (4,000)
Decrease (increase) in:
Premium due and uncollected, unearned
premium and premium received in advance (144) (870)
Prepaid interactive marketing expense (2,610) 0
Due to/from reinsurers (14,659) 3,236
Due from third party administrator 6,849 (7,117)
Deferred policy acquisition costs, net (99) (2,445)
Accrued investment income 76 48
Other assets, current and deferred income
taxes and other liabilities 81 (3,475)
Accrued commissions and expenses (322) (3,973)
Unearned ceding commissions and interest 300 0
Future policy benefits and claims (15,059) 2,445
--------- ----------
Net cash used in operating activities (36,474) (15,395)
--------- ----------
Cash flows from investing activities
Purchases of bonds 0 (2,674)
Purchases of equity securities 0 (26)
Sale of bonds 5,979 4,727
Sale of equity securities 0 4,000
Maturity of investments and loans 21 0
Loans to officer, director and shareholder 686 (41)
Purchases of property and equipment (1,147) (772)
--------- ----------
Net cash provided by investing activities 5,539 5,214
--------- ----------
</TABLE>
Continued on next page.
See notes to consolidated financial statements.
Page 7 of 31 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Continued)
(Dollars in thousands)
<TABLE>
<CAPTION>
6 Months Ended June 30,
1999 1998
------ ------
<S> <C> <C>
Cash flows from financing activities
Withdrawals from contractholder deposit funds (250) (590)
Repayments of loans payable (1,465) (278)
Issuance of convertible note 0 5,000
Issuance of HealthAxis common stock 6,281 4
Issuance of HealthAxis preferred stock, net 8,123 0
Exercise of stock options 4,665 0
Dividends paid on preferred and common stock (70) (74)
--------- --------
Net cash from financing activities 17,284 4,062
--------- --------
Decrease in cash and cash equivalents (13,651) (6,119)
Cash and cash equivalents, beginning of period 26,185 16,767
--------- --------
Cash and cash equivalents, end of period $ 12,534 $ 10,648
--------- --------
Supplemental disclosure of cash flow information:
Interest paid $ 453 $ 102
Non-cash investing activities
Sale of subsidiary $ 1,500 0
Capital lease obligations $ 154 0
Non-cash financing activities:
Issuance of warrants $ 867 $ 990
Exercise of options and warrants $ 1,513 0
Repayment of loans payable $ (2,400) 0
</TABLE>
See notes to consolidated financial statements.
Page 8 of 31 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
Note A - General
The condensed consolidated financial statements have been prepared by
Provident American Corporation and subsidiaries (the "Company") without audit,
pursuant to the rules and regulations of the Securities and Exchange Commission
and reflect all adjustments which, in the opinion of the Company, are necessary
to present fairly results for the interim periods. Certain financial information
and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles have been condensed or
omitted pursuant to such rules and regulations, although the Company believes
that the accompanying disclosures are adequate to make the information presented
not misleading. Results of operations for the six-month period ended June 30,
1999, are not necessarily indicative of the results that may be expected for the
year ending December 31, 1999.
These financial statements should be read in conjunction with the
financial statements and notes thereto contained in the Company's Annual Report
on Form 10-K/A for the year ended December 31, 1998.
Certain prior year amounts have been reclassified to conform with the
current presentation.
Provident American Corporation ("PAMCO") is a Pennsylvania corporation
organized in 1982 and regulated as an insurance holding company by the states in
which its wholly owned insurance company, Provident Indemnity Life Insurance
Company ("PILIC"), is licensed. The operations of the Company are principally
those of its majority-owned subsidiary HealthAxis.com, Inc.
("HealthAxis") and its Insurance Operations as defined below.
HealthAxis was formed on March 26, 1998 to sell insurance products on
the Internet. HealthAxis is a subsidiary of Provident American Corporation,
which owns 73.8% of HealthAxis' capital stock. Health Plan Services ("HPS") and
other accredited investors, own 12.2% and 14.0%, respectively, of the remaining
capital stock. PAMCO and HealthAxis are currently in the process of negotiating
the terms of a merger whereby HealthAxis will be merged with and into HealthAxis
Acquisition Corp., a wholly-owned subsidiary of Provident, and PAMCO will be the
surviving publicly-traded company, with HealthAxis being a wholly owned
subsidiary. Management believes the merger will be completed during 1999. No
assurances can be given as to the exchange ratio or other material terms of the
proposed reorganization, whether or not the reorganization will be completed or,
if completed, the timing thereof.
The Company's Insurance Operations are conducted through its wholly
owned life insurance subsidiary PILIC and PILIC's subsidiaries which during 1996
through 1998 were Provident American Life and Health Insurance Company
("PALHIC"), Montgomery Management Corporation ("MMC") and NIA Corporation
("NIA"). Hereinafter PILIC and all of its subsidiaries are referred to as the
Company's Insurance Operations. During 1998, the Company sold 80% of MMC's
outstanding common stock and on December 31, 1998 sold 100% of the outstanding
common stock of PALHIC and NIA. During the first quarter of 1999 the Company
sold the remaining 20% of MMC's common stock. As described in Note J, the
Company has entered into a definitive agreement to sell PILIC.
Page 9 of 31 Pages
<PAGE>
Note B - Losses and Uncertainties
The Company has incurred costs to develop and enhance its technology,
to create and introduce its website and to establish marketing, insurance
carrier and claims administration relationships. As a result, the Company has
incurred significant losses and expects to continue to incur losses on a
quarterly basis at least through 2000. The Company currently intends to
substantially increase its operating expenses as a result of its strategic
alliances, to fund increased interactive sales and marketing, to enhance its
existing web site and to fund increased salaries and other costs. Consequently,
the Company expects negative cash flow from operations to continue for the
foreseeable future as it continues to develop and market its Internet-based
health and life insurance business.
During 1999, HealthAxis completed a private placement offering of
approximately $8,800 of HealthAxis Series C Preferred Stock on March 30, 1999
(described in Note H), approximately $6,200 of HealthAxis Common Stock
(described in Note F) solely to "accredited investors" (as defined in Rule 501
of Regulation D under the Securities Act) on May 11, 1999, and approximately
$4,000 of HealthAxis Series D Preferred Stock (described in Note M) on July 12,
1999. The net proceeds have been used to and are anticipated to be used to fund
amounts due under the Company's distribution agreements with America Online,
Inc. ("AOL"), Lycos, Inc. ("Lycos"), CNet, Inc. ("CNet") and Snap! LLC ("Snap")
through the end of fiscal 1999, and the balance is intended to be used by
HealthAxis for its working capital and other general purposes. The Company
believes that the above net proceeds together with its current cash and cash
equivalents will be sufficient to fund HealthAxis' current operations and
amounts due to AOL, Lycos, CNet and Snap during 1999. However, subsequent equity
or debt financings will be necessary to enable the Company to fund operations
and continue to implement its current business strategies.
The Company has incurred losses in its Insurance Operations during 1999
and in prior years and is pursuing the reinsurance of PILIC's life and annuity
inforce business and the sale of PILIC as described in Note J. PAMCO anticipates
the need to raise capital through the private sale of either debt or equity
securities for working capital and other general corporate purposes including
approximately $8,300 to purchase HealthAxis Common Stock as described in Note I
and $14,700 to sell the Insurance Operations and retain the Company's home
office and 445,916 shares of HealthAxis Series A Preferred Stock as described in
Note J, thereby completing the Company's transition from insurance underwriter
to an internet insurance broker. No assurances can be given with regard to the
success, terms or timing of the Company's efforts to obtain such funding. In the
event PAMCO is unable to obtain funding and pay $7,040 by October 31, 1999 to
HPS it will be in breach of its Stock Purchase Agreement with HPS and will be
unable to sell its Insurance Operations or maintain sufficient statutory capital
and surplus levels in PILIC needed to avoid regulatory intervention which may
include oversight and, ultimately rehabilitation or liquidation of PILIC.
Note C - Changes in Web Alliances
On April 14, 1999, the Company and CNet amended the Promotion Agreement
dated June 14, 1998, as amended on November 13, 1998 (the "Amended Agreement")
to, among other things, revise the current payment schedule, to remove Snap as a
party to the agreement and enter into a separate agreement with Snap, as CNet
and Snap are now separate entities. The Amended Agreement and the Snap
Page 10 of 31 Pages
<PAGE>
Agreement extends the termination date of the initial term of the agreement to
August 31, 2000; allocates the total number of monthly impressions between Snap
and CNet; provides CNet and Snap with the ability to immediately terminate the
Amended Agreement and Snap Agreement for nonpayment of fees due or to charge
interest on all unpaid amounts at a rate of 1-1/2% per month; revises the
exclusivity provisions of the Snap Agreement; and revises the payment schedule
applicable to the optional term. The Snap Agreement also provides for the
permanent placement of a Company banner on the Snap Health Insurance Center to
be created within the Business and Money Channel on the Snap website and
provides that HealthAxis and Snap shall work together to develop a co-branded
site.
Note D - Prepaid Interactive Marketing Expense
During 1999, HealthAxis made payments aggregating $2,610 to AOL, Lycos,
CNet, and Snap, $2,360 of which have been charged, to prepaid interactive
marketing expense and $250 of which reduced accrued expenses. Included in
Interactive sales and marketing expense is amortization of prepaid interactive
marketing expense of $4,990 consisting of exclusivity expense and impression
advertising of $1,496 and $3,494, respectively for 1999.
Note E - HealthAxis Warrants Issued in Connection with Alliance Agreements
During 1999, in connection with its amended Carrier Partner agreement
with UICI, HealthAxis agreed to issue UICI a warrant to purchase 150,000 shares
of HealthAxis Common Stock at an exercise price of $4.40 per share with a
five-year term. This warrant has been valued at $505, recorded as prepaid
alliance agreement expense included in other assets and will be expensed over
the life of the agreement beginning July 1, 1999. In the event AOL exercises its
redemption rights set forth in the Certificate of Designation related to the
Series B Preferred Stock, UICI shall receive a warrant to purchase an additional
200,000 shares of HealthAxis' Common Stock at an exercise price of $3.00 per
share.
In May 1999, HealthAxis entered into a Strategic Alliance Agreement
with First Health Group Corp. ("First Health"). In conjunction with this
agreement, HealthAxis issued a warrant to First Health for 50,000 shares of
HealthAxis Common Stock at $20.00 per share with a three-year term. Of that
amount, warrants to purchase 10,000 shares are immediately exercisable, have
been valued at $84 and recorded as prepaid alliance agreement expense included
in other assets. The remaining warrants become exercisable at the rate of 10,000
warrants upon the signing of each sub-client agreement with each carrier, until
the fourth carrier is signed. In addition, if the average daily closing price of
HealthAxis' Common Stock is $50.00 per share for a period of 60 consecutive
calendar days and if no sub-client agreement has been executed, 10,000 shares
subject to this warrant which are not exercisable shall become exercisable in
full.
Page 11 of 31 Pages
<PAGE>
Note F - Minority Interest in HealthAxis.com, Inc.
The Company has accounted for the portion of HealthAxis owned by
outside parties as Minority Interest in HealthAxis. The chart below identifies
the equity ownership of HealthAxis Common Stock and quantifies the Company's
majority interest and the minority interest in HealthAxis Common Stock.
<TABLE>
<CAPTION>
June 30, 1999 December 31, 1998
------------- -----------------
Shares Percentage Shares Percentage
------ ---------- ------ ----------
<S> <C> <C> <C> <C>
PAMCO 13,807,395 82.5% 13,807,395 85.4%
Minority Interest 2,931,416 17.5% 2,365,365 14.6%
---------- ----- ----------- -----
Total 16,738,811 100.0% 16,172,760 100.0%
========== ===== ========== =====
</TABLE>
The aforementioned outstanding shares of HealthAxis Common Stock
exclude options and warrants to purchase HealthAxis Common Stock and HealthAxis
convertible preferred stock convertible into HealthAxis Common Stock. As
described in Note I, the Company has agreed to purchase up to 1,415,000 shares
of HealthAxis Common Stock from HPS currently included in minority interest.
The Company has also accounted for the net proceeds of HealthAxis
cumulative preferred stock, par value $1 Series B ("HealthAxis Series B
Preferred Stock) held by AOL as described in Note G and Series C ("HealthAxis
Series C Preferred Stock") as described in Note H as minority interest. The
Company will account for the net proceeds of HealthAxis Series D Preferred Stock
issued on July 12, 1999 as minority interest described in Note M.
The Company has accounted for the 545,916 shares of HealthAxis
cumulative preferred stock, par value $1 Series A ("Series A Preferred Stock")
purchased by PILIC in 1998 for an aggregate consideration of $2,400, or $4.40
per share, as an investment in HealthAxis. The Series A Preferred Stock is
convertible into HealthAxis Common Stock on a one for one basis, subject to
adjustment. Each share of Series A Preferred Stock has the same voting rights as
a share of HealthAxis Common Stock into which it is convertible and has certain
preferences with respect to the payment of dividends and upon liquidation over
HealthAxis Common Stock.
On May 11, 1999, HealthAxis completed a private placement of 516,051
shares of HealthAxis Common Stock to a group of accredited investors at $12 per
share for an aggregate purchase price of $6,193, less issuance costs of $2. The
net proceeds of $6,191, will be used by HealthAxis for working capital and other
general corporate purposes, including marketing expenses, web site enhancements,
salary expenses and advertising and promotional expenses. Investors purchasing
HealthAxis Common Stock were provided with registration rights described in the
Company's Form 8-K filed on May 14, 1999.
Note G - HealthAxis.com, Inc. Series B Cumulative Convertible Preferred Stock
During 1998, HealthAxis issued 625,529 shares of HealthAxis Series B
Preferred Stock to AOL at $4.40 per share for an aggregate purchase price of
$2,750, less issuance costs amounting to $51, of which a portion of such net
proceeds was used to pay amounts due to AOL under the Interactive Marketing
Agreement. The terms of the HealthAxis Series B Preferred Stock are described in
the Company's Form 8-K filed on December 23, 1998.
Page 12 of 31 Pages
<PAGE>
Dividends. As of June 30, 1999, HealthAxis accrued $105 of unpaid
dividends on Series B Preferred Stock. Prior to March 30, 1999, holders of the
Series B Preferred Stock were entitled to cumulative dividends accruing from the
date of issuance, as and if declared by the HealthAxis board of directors out of
funds legally available therefor, at the annual rate of $.13 per share (subject
to equitable adjustment to reflect stock splits, stock dividends, stock
combinations, recapitalizations and similar occurrences).
Optional Redemption. Holders of the HealthAxis Series B Preferred Stock
have the option, exercisable upon request of the holders of 51% of the
outstanding shares of HealthAxis Series B Preferred Stock within six months
after the later of the occurrence of a Trigger Event (as defined below) or
notice of a Trigger Event, to cause HealthAxis to redeem any or all of the
shares of HealthAxis Series B Preferred Stock requested to be redeemed, at a
redemption price per share equal to the original issuance price (subject to
adjustment to reflect stock splits, stock dividends, stock contributions,
recapitalizations and similar occurrences) plus an amount that would yield a
total annualized return of 10% calculated daily and compounded annually from the
later of either the original issuance date or the date on which the holder
acquired the shares of HealthAxis Series B Preferred Stock through the date of
redemption. Notice of the exercise of the optional redemption rights with
respect to the HealthAxis Series B Preferred Stock must be given to HealthAxis
pursuant to the notice of optional redemption provision contained in the
Certificate of Designation related to the HealthAxis Series B Preferred Stock.
A "Trigger Event" means: (i) January 31, 2002, if by that date,
HealthAxis has not consummated an underwritten public offering of newly issued
HealthAxis Common Stock pursuant to a registration statement filed under the
Securities Act, at a net offering price per share of HealthAxis Common Stock
that represents a pre-offering market capitalization of not less than $150,000
and with aggregate proceeds of not less than $25,000, (ii) failure to renew by
HealthAxis or a material breach by any party other than AOL or termination of
the IM Agreement with AOL, (iii)the date of the occurrence of a liquidation of
HealthAxis, (iv) March 31, 1999, if by that date, HealthAxis has not consummated
an equity financing yielding aggregate gross proceeds to HealthAxis of not less
than $7,000 at a price per share of at least $3.74 (a "Qualified Financing"), or
(v) May 31, 1999, if by that date, HealthAxis has not consummated an equity
financing yielding aggregate gross proceeds to HealthAxis of not less than
$3,500 at a price per share of at least $3.74 (a "Second Qualified Financing").
As described in Note H, HealthAxis completed an equity financing in the amount
of $8,807 as of March 30, 1999 and as described in Note F HealthAxis completed
an equity financing in the amount of $6,193 on May 11, 1999.
Note H - HealthAxis.com, Inc. Series C Cumulative Convertible Preferred Stock
On March 30, 1999, HealthAxis issued 1,526,412 shares of HealthAxis
Series C Preferred Stock to a group of accredited investors at $5.77 per share
for an aggregate purchase price of $8,807, less issuance costs of $684 and the
value of warrants to purchase HealthAxis common stock issued in connection with
the issuance of HealthAxis Series C Preferred Stock to certain professional
service firms valued at $278. The net proceeds of $8,123, will be used for
working capital and other general corporate purposes, including marketing
expenses, web site enhancements, salary expenses and advertising and promotional
expenses of HealthAxis.
The terms of the HealthAxis Series C Preferred Stock are described in
the Company's Form 8-K filed on April 30, 1999.
Page 13 of 31 Pages
<PAGE>
Note I - Stock Purchase Agreement to buy-back HealthAxis Common Stock from HPS
On May 13, 1999 PAMCO entered into a stock purchase agreement ("HPS Stock
Purchase Agreement") for the purchase of 1,415,000 shares of HealthAxis no par
value common stock from HPS for $7,040 to close on or before June 30, 1999. The
HPS Stock Purchase Agreement allows for closing to occur on or before October
31, 1999 with the purchase price per share increasing by 8 1/2% per month for
the months of August, September and October until closing. The HPS Stock
Purchase Agreement also allows PAMCO the option of purchasing fewer shares so
long as the aggregate purchase price is not less than $7,040. PAMCO did not
close the transaction on June 30, 1999 and paid HPS a late fee of $100 to extend
closing in accordance with the HPS Stock Purchase Agreement.
Note J - Insurance Operations
On August 16, 1999, the Company entered into a definitive agreement to
sell all of the outstanding shares of the common stock of PILIC to AHC
Acquisition, Inc. ("AHC"), a newly formed Pennsylvania business corporation,
which is owned by Alvin H. Clemens, the Company's Chairman of the Board of
Directors. The agreement calls for PAMCO, at or prior to closing, to pay $14,700
to PILIC for the purchase of PILIC's home office building, the purchase of
545,915 shares of HealthAxis.com, Inc. Series A Preferred Stock and a capital
contribution, if any. In addition, PAMCO will transfer to AHC 100,000 shares of
Series A Convertible Preferred Stock of HealthAxis.com, Inc. in connection with
the obligations assumed by AHC at the closing. The Company anticipates that upon
the completion of the closing, PAMCO will not have any liability whatsoever with
respect to the insurance, capital and surplus, and business operations of PILIC,
except for the ceding commission liability with the Reassurance Company of
Hanover ("RCH") in connection with the December 31, 1998 transactions with Ceres
Group. The Company anticipates that the transaction will close as soon as
practical after receiving appropriate approvals and financing. The Company
further anticipates that the sale of PILIC will result in a loss, the amount of
which is under evaluation at this time, and will be reported in Form 8-K.
No assurances can be given as to whether or not the transactions will
be completed or, if completed, the timing thereof, receipt of required
regulatory and contractual approvals and obtaining necessary cash financing.
Accordingly, the Company also anticipates that the results of operations and the
net assets or liabilities of the Insurance Operations will be reported as
discontinued operations effective with obtaining the necessary regulatory
approvals.
Page 14 of 31 Pages
<PAGE>
Note K - Reinsurance and Deferred Acquisition Cost Impact on Benefits and
Expenses
Accident and health policy benefits, commissions and other operating
expenses are net of the following ceded reinsurance and deferred acquisition
cost amounts:
<TABLE>
<CAPTION>
3 Months Ended June 30, 6 Months Ended June 30,
1999 1998 1999 1998
---- ---- ---- ----
<S> <C> <C> <C> <C>
Accident and health benefits
Gross before reinsurance ceded $18,501 $ 21,771 $ 34,958 $ 41,029
Less reinsurance ceded 16,334 11,990 32,386 19,153
------- -------- -------- --------
Net of reinsurance $ 2,167 $ 9,781 $ 2,572 $ 21,876
======= ======== ======== ========
Commissions
Gross before reinsurance ceded $ 3,598 $ 7,352 $ 7,650 $ 14,883
Less reinsurance ceded 2,987 3,360 6,595 7,275
Less deferred acquisition costs 164 1,406 351 2,285
------- -------- -------- --------
Net $ 447 $ 2,586 $ 704 $ 5,323
Other operating expenses
Gross before reinsurance ceded $ 5,840 $ 6,866 $ 8,960 $ 14,121
Less reinsurance ceded 22 1,333 37 3,062
Less deferred acquisition costs (1) 284 38 700
------- -------- -------- --------
Net $ 5,819 $ 5,249 $ 8,885 $ 10,359
======= ======== ======== ========
</TABLE>
Effective December 31, 1998, the Company and PILIC signed an agreement
to reinsure 100% of its group medical and group life inforce business and sell
the Company's group medical marketing, sales distribution rights and all of the
outstanding capital stock of PALHIC to Central Reserve Life Insurance Company
("CRLC") (the "CRLC Agreement").
Under the CRLC Agreement, PALHIC reinsured 100% of its business to
PILIC, which in turn reinsured through a 100% coinsurance agreement, all of the
Company's group medical and group life business to RCH. In addition, PILIC sold
all of the outstanding shares of PALHIC and NIA to CRLC for an amount equal to
PALHIC's capital and surplus. The Company transferred all rights and control
regarding the Company's licensed insurance agents and entered into a non-compete
and non-solicitation agreements with CRLC regarding the Company's licensed
insurance agents with respect to the future sale of health insurance products
for a three year period.
Effective December 31, 1998, PILIC entered into a coinsurance agreement
with RCH whereby PILIC received a $10,000 ceding commission which consisted of a
$5,000 non-refundable payment and a $5,000 payment contingent upon RCH's earning
at least $10,000 in future profits from the ceded inforce business, plus 12%
interest (the "guaranteed amount"). PILIC recognized the $10,000 as ceding
commission revenue net of transaction costs of $417 and PAMCO recognized a
$5,000 ceding commission liability because of the negative financial history of
the business. As a result of the transaction, PILIC wrote-off unamortized
deferred acquisition costs and restructuring costs aggregating $4,200.
Page 15 of 31 Pages
<PAGE>
If RCH fails to earn the guaranteed amount within five years of the
date of the closing of the CRLC transaction, PAMCO must repay RCH the lesser of
the guaranteed amount less RCH's actual profits on the inforce business, or
$5,000, plus 12% interest. In the unlikely event that future profits exceed the
guaranteed amount, then PILIC is entitled to receive an additional payment from
RCH equal to two-thirds of the policy fees collected during 1999 and one-third
of the policy fees collected during 2000.
As security for PAMCO's guarantee, PAMCO executed a security agreement
in favor of RCH secured by the stock of PILIC. This agreement provides that RCH
will take ownership of PILIC if the Company defaults on its guarantee to RCH.
PAMCO provided various affirmative covenants regarding corporate existence;
compliance with laws; furnishing various notices to RCH; inspection and audit
rights and insurance coverage. Additionally, PAMCO provided certain negative
covenants with regard to selling, assigning, leasing or otherwise disposing of
PAMCO or PILIC assets; entering into agreements materially and adversely
effecting PAMCO's or PILIC's ability to carry on business; entering into an
agreement materially and adversely effecting PAMCO or PILIC ability to perform
obligations under the Guaranty, the reinsurance agreement with RCH, the Stock
Purchase Agreement and other related agreements. There also exist various
provisions regarding PAMCO or PILIC incurring or creating indebtedness or
declaring dividends.
Under the CRLC Agreement, PILIC has the right to assume new business
written by PILIC's agents for five years after the effective date of the CRLC
Agreement. The Company has determined not to assume any business from CRLC.
During the first quarter of 1999, the Company decided to cease its
participation via assumption reinsurance of stop loss business administered by
MMC.
Reinsurance does not relieve the Company of its primary obligations to
its policyholders and varies according to the age of the insured, type of risk
and type of policy. Retention amounts for life insurance range up to $50 of
coverage per individual life and for health insurance up to $85 per individual.
During 1998, the Company had Quota Share Reinsurance and Excess of Loss
Reinsurance arrangements on its group medical insurance with a group of
reinsurers which were terminated by the Company effective December 31, 1998 in
connection with the reinsurance and other agreements with RCH and CRLC.
The Company's medical quota share and excess reinsurance agreements
with Swiss Re were terminated effective December 31, 1997. Swiss Re's obligation
to assume its proportionate share of medical paid losses incurred prior to
January 1, 1998 remains in effect. The amount of reinsurance recoveries from
Swiss Re is currently in dispute and Swiss Re has refused further payment. The
Company has provided Swiss Re with a Notice of Default and has asserted its
rights under the reinsurance contract. Nonetheless, The Company has recognized
an allowance for uncollectability for a portion of the amounts due from
Swiss Re.
In addition, the Company generally assumes 30% (up to $150 per
individual) of the liability on its limited self-funded accident and health
business, which consists generally of policies issued to limit the claims
expenses of employers that self-insure group medical benefits with respect to
any individual employee and in the aggregate.
Page 16 of 31 Pages
<PAGE>
Note L - Settlement Agreement with HPS
Sale of Montgomery Management: Effective March 31, 1999 the Company
sold its remaining 20% of MMC common stock to HPS for a purchase price of
$1,500, payment of which was made by a set off of a like amount against future
service fees, accounted for a loan payable, owed by the Company to HPS. The
Company recognized a $1,500 pre-tax gain on the sale.
In a previous agreement, in February 1998 the Company sold for $4,000
49% of MMC common stock along with a warrant to purchase an additional 31% of
MMC's common stock for one dollar per share. Immediately prior to the sale MMC
declared a dividend payable to its parent PILIC equal to its total equity.
During the fourth quarter of 1998, the buyer exercised the warrant to purchase
the additional 31% of MMC's Common Stock for $8. The Company recognized a $4,000
pre-tax gain on the sale of MMC in 1998. Effective with the sale in 1998, the
Company includes MMC in the Company's consolidated financial statements on the
equity basis.
Commitment to pay outstanding HPS service fees to HPS: In conjunction
with the sale of MMC described above, PAMCO entered into a settlement agreement
to resolve a number of disputes that have arisen between the Company and HPS
relative to HPS' performance of administrative services under the HPS
Outsourcing Agreement of the now ceded block of Provident health business. The
companies agreed to settle all differences and claims related to the HPS
Outsourcing Agreement and certain actions taken by HealthAxis regarding
HealthAxis' obligations under certain agreements between the parties. Also in
accordance with the terms of the settlement agreement, HPS exercised a warrant
granted in 1998 in connection with the HPS E-commerce Agreement, and purchased
100,000 shares of the common stock of PAMCO for a purchase price of $900. The
purchase price was paid by a set off of a like amount against the service fees
owed by the Company to HPS. The Company paid the remaining balance of the
services fees owed to HPS in the amount of $1,267 to HPS on June 30, 1999,
whereupon the Company's obligation to pay service fees was terminated.
Note M - Subsequent Events
HealthAxis issuance of Series D Preferred Stock: On July 12, 1999,
HealthAxis completed a private placement of 333,334 shares of HealthAxis Series
D Preferred Stock to Intel Corp at $12 per share for an aggregate purchase price
of $4,000, less issuance costs estimated to approximate $5. The net proceeds of
approximately $3,995, will be used for working capital and other general
corporate purposes, including marketing expenses, web site enhancements, salary
expenses and advertising and promotional expenses of HealthAxis.
In connection with the HealthAxis Series D Offering, HealthAxis'
Amended and Restated Articles of Incorporation were amended to authorize an
additional 500,000 shares of HealthAxis Preferred Stock.
The terms of the HealthAxis Series D Preferred Stock are described in
the Company's Form 8-K filed July 26, 1999.
Page 17 of 31 Pages
<PAGE>
Note N - Selected HealthAxis Financial Data
The following table list selected financial data relates to regarding the
Company's majority owned subsidiary HealthAxis included in the Company's
consolidated financial statements. All amounts are in thousands.
<TABLE>
<CAPTION>
UNAUDITED
6 Months Ended 12 Months Ended
June 30, 1999 June 30, 1998 December 31, 1998
<S> <C> <C> <C>
Statement of operations data:
Commission and fee revenue $ 41 $ 0 $ 0
Interest income 97 0 0
------- ------ -------
Total revenue 138 0 0
------- ------ -------
Total expenses 9,996 968 4,790
------- ------ -------
Net loss $(9,858) $ (968) $(4,790)
Dividends on preferred stock 129 0 106
------- ------ -------
Net loss applicable to common stock $(9,987) $ (968) $(4,896)
======= ====== =======
(Loss) per share of HealthAxis common stock, basic and diluted
$ (0.61) $(0.07) $ (0.35)
Weighted average common shares and equivalents used in
computing (loss) per share 16,347 13,125 14,027
Balance sheet data:
Total assets $21,368 $ 7,237 $14,876
Total liabilities $ 3,321 $ 7,127 $ 1,919
Redeemable preferred stock $ 2,804 $ 0 $ 2,735
Total equity $15,243 $ 110 $10,222
</TABLE>
Note O - Investment Considerations
In analyzing whether to make, or continue, an investment in the Company,
investors should consider, among other factors, certain investment
considerations more particularly described in the Company's Annual Report on
Form 10-K/A for the year ended December 31, 1998, a copy of which can be
obtained from the Company.
Page 18 of 31 Pages
<PAGE>
Note P - Forward-looking Statements
The information contained in the Quarterly Report on form 10-Q for the
quarter ended June 30, 1999 contains forward-looking statements (as such term is
defined under Section 21E of the Securities Exchange Act of 1934 and the
regulations thereunder), including without limitation, statements as to trends,
management's beliefs, expectations or opinions, which are based upon a number of
assumptions concerning future conditions that ultimately may prove to be
inaccurate.
Such forward-looking statements are subject to risks and uncertainties
and may be affected by various factors, which may cause actual results to differ
materially from those in the forward-looking statements. Certain of these risks,
uncertainties and other factors are discussed in the Company's Annual Report on
Form on 10-K/A for the year ended December 31, 1998.
Page 19 of 31 Pages
<PAGE>
Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations.
Overview
During 1998 the Company revised its strategy to focus predominately on
HealthAxis, the Company's e-commerce insurance marketing subsidiary. In early
1998 the Company determined that the Internet provided the opportunity to sell
health and life insurance directly to consumers thereby reaching individuals at
a cost potentially lower than traditional agency marketing channels. In light of
the losses experienced in the Company's small group and managed care products
and the need to focus on HealthAxis and deploy capital to it, the Company
entered into various agreements to sell PILIC's subsidiaries (MMC, PALHIC and
NIA) and cede 100% of the group medical and group life business during 1998.
On December 31, 1998, the Company executed a series of transactions
whereby PALHIC reinsured 100% of its business to PILIC, which in turn reinsured
via a 100% co-insurance reinsurance agreement all of the Company's group medical
and group life business to the RCH. In addition, PILIC sold PALHIC and NIA to
CRLC, transferred all rights and control regarding the Company's agents and
entered into non-compete and non-solicitation agreements regarding the Company's
agents with respect to the future sale of health insurance products by agents
for a 3-year period.
During the second quarter of 1999 the Company announced that it was
pursuing the sale of its Insurance Operations. As described in Note J of the
Notes to Financial Statements, the Company has entered into a definitive
agreement to sell PILIC.
HealthAxis is an Internet-based distributor of health insurance
products. The Company has no knowledge of any other fully transaction-enabled
direct distributor of individual and small group health insurance products.
Currently HealthAxis markets individual coverage in 22 states, with nationwide
coverage planned. HealthAxis anticipates offering a full range of health and
life insurance products for individuals and small groups, including policies for
prescription drugs, vision care, dental coverage, critical care, long-term care,
long term disability and life insurance. HealthAxis is building a nationwide
product portfolio through sourcing relationships with leading insurance
companies ("Carrier Partners"), including the following: Aegon, WellPoint Health
Networks, Fortis, UICI and Security Life, among others. The Company anticipates
that HealthAxis will enter into additional agreements with other insurance
companies. HealthAxis markets to consumers through its web site
(www.HealthAxis.com) and through the following Internet services with which
HealthAxis possesses exclusive marketing rights: AOL, Lycos, CNet and Snap.
On December 3, 1998, HealthAxis commenced a launch of its operational
web site with distribution principally via the AOL relationship. The Company
expanded its online reach with the commencement of additional distribution on
Lycos in May 1999 and CNet and Snap in June 1999.
HealthAxis has experienced an increase in revenues during 1999 due to
increased traffic and website enhancements. This revenue was attributable to the
one Carrier Partner currently available on the site. As additional Carrier
Partners and products become available on the site, the Company anticipates
revenues to increase.
Page 20 of 31 Pages
<PAGE>
PAMCO and HealthAxis are currently in the process of negotiating the
terms of a merger whereby HealthAxis will be merged with and into HealthAxis
Acquisition Corp., a wholly-owned subsidiary of Provident, and PAMCO will be the
surviving publicly-traded company, with HealthAxis being a wholly owned
subsidiary. Management believes the merger will be completed during 1999. No
assurances can be given as to the exchange ratio or other material terms of the
proposed reorganization, whether or not the reorganization will be completed or,
if completed, the timing thereof.
Results of Operations
For the three months ended June 30, 1999 ("the current quarter") the
net (loss) applicable to Common Stock was ($10.5 million) or ($0.88) per diluted
share compared to net (loss) of ($2.4 million) or ($0.20) per diluted share for
three months ended June 30, 1998 ("the same period last year"). The Company's
net loss is the result of increased expenses in both HealthAxis and Insurance
Operations.
Accident and health gross premium was $23.8 million for the current
quarter compared to $27.2 million for the same period last year. Accident and
health ceded premium was $22.8 million for the current quarter compared to $13.1
million for the same period last year. As a result of the transactions with CRLC
and RCH, the Company has experienced a substantial decline in net earned premium
in comparison to 1998. Effective in 1999, the Company has ceded 100% of the
Company's small group and managed care premium to RCH. During the first quarter,
the Company also decided to cease its participation via assumption reinsurance
of stop loss business administered by MMC. The Company has also determined not
to assume any business from CRLC. As a consequence of these decisions, the
Company's net health premium is expected to decline to a nominal amount by the
end of 1999.
Life and annuity premium, gross of $1.7 million for the current quarter
declined from $2.0 million for the same period last year due to reduced pre-need
premium. Life and annuity reinsurance ceded of $0.4 million increased from the
same period last year as a result of the transactions with CRLC and RCH. As
described in Note J of the Notes to Financial Statements, the Company is
pursuing the reinsurance of its remaining life business, which, if effected,
would effectively reduce future life net premiums to zero.
Net investment income of $0.7 million in the current quarter decreased
from $1.0 million in the same period last year as a result of reduced bond and
short-term investment balances. The Company anticipates that investment income
will continue to decline as the Company pays off remaining claim liabilities
from one life group medical business. As described in Note J of the Notes to
Financial Statements, the Company is pursuing the reinsurance of its remaining
life business, which, if completed, would substantially reduce invested assets
and, accordingly, substantially reduce future net investment income.
Accident and health, net of reinsurance expense of $2.2 million in the
current quarter decreased from $9.8 million in the same period last year as a
result of the transactions with CRLC and RCH, offset by greater than anticipated
claims experience on the Company's one life group medical business. Although the
Company believes policy claim liabilities for small group and managed care
business as of June 30, 1999 are adequate, greater than anticipated claim
experience could have a materially adverse impact on the Company's financial
position and results of operations.
Page 21 of 31 Pages
<PAGE>
Commissions, net of ceding allowance and deferred acquisition costs of
$0.4 million in the current quarter decreased from $2.6 million in the same
period last year as a result of the transactions with CRLC and RCH.
Other operating expenses, net of ceding allowance and deferred
acquisition costs of $5.8 million for the current quarter increased from $5.2
million in the same period last year primarily due to an allowance for Insurance
Operations uncollectable receivables and higher expense associated with
HealthAxis due primarily to employee and recruiting expenses related to software
engineering, carrier integration, website enhancements, and general operations
partially offset by lower expenses in the Company's Insurance Operations as a
result of the transactions with CRLC and RCH. To support the HealthAxis business
strategy, operating and development expenses will increase as more carriers and
products are integrated and website enhancements are made.
Interactive sales and marketing expense of $4.7 million for the current
quarter increased from $0.5 million in the same period last year due primarily
to the amortization of HealthAxis' interactive marketing agreements based on the
number of impressions received by the website. Interactive marketing
amortization was $3.6 million for the current quarter. In addition, HealthAxis
employee and recruiting expense increased. The Company expects the impression
amortization to increase as additional carriers and products are introduced to
the website. The number of personnel and the amount spent on advertising through
on-line and traditional advertising will also increase in order to promote the
Company's Internet products.
For the six months ended June 30, 1999 ("1999") the net (loss)
applicable to common stock was ($13.4) million or ($1.14) per diluted share
compared to net gain of $0.3 million or $0.02 per diluted share for six months
ended June 30, 1998 ("1998"). The Company's results included gains on the sale
of MMC's common stock in 1999 and 1998 of $1.5 million and $4.0 million,
respectively as described in Note L of the Notes to Financial Statements.
Accident and health gross premium was $49.3 million for 1999 compared
to $55.9 million for 1998. Accident and health ceded premium was $47.8 million
for 1999 compared to $24.8 million for 1998. As a result of the transactions
with CRLC and RCH, the Company has experienced a substantial decline in net
earned premium in comparison to 1998.
Life and annuity premium, gross of $3.4 million for 1999 declined from
$4.6 million for 1998 due to reduced pre-need premium. Life and annuity
reinsurance ceded of $0.8 million increased from 1998 as a result of the
transactions with CRLC and RCH.
Realized gain on the sale of subsidiary of $1.5 million in 1999 and
$4.0 million in 1998 consisted of realized gains on the sale of 20% and 80%,
respectively, of MMC to HPS as described in Note L of the Notes to Financial
Statements.
Page 22 of 31 Pages
<PAGE>
Accident and health, net of reinsurance expense of $2.6 million in 1999
decreased from $21.9 million in 1998 as a result of the transactions with CRLC
and RCH offset by greater than anticipated claims experience on the Company's
one life group medical business.
Commissions, net of ceding allowance and deferred acquisition costs of
$0.7 million for 1999 decreased from $5.3 million in 1998 as a result of the
transactions with CRLC and RCH.
Other operating expenses, net of ceding allowance and deferred
acquisition costs of $8.9 million for 1999 decreased from $10.4 million in 1998
primarily due to lower expenses in the Company's Insurance Operations as a
result of the transactions with CRLC and RCH partially offset by an allowance
for Insurance Operations uncollectable receivables and $3.2 million of higher
expense associated with HealthAxis due primarily to employee and recruiting
expenses related to software engineering, carrier integration, website
enhancements, and general operations.
Interactive sales and marketing expense of $6.4 million for 1999
increased from $0.6 million in 1998 due primarily to the amortization of
HealthAxis' interactive marketing agreements based on the number of impressions
received by the website. Interactive marketing amortization was $5.0 million for
1999. In addition, HealthAxis employee and recruiting expense increased.
Liquidity and Capital Resources
A major objective of the Company is to maintain sufficient liquidity to
fund growth, fulfill statutory requirements and meet all cash requirements with
cash and short term equivalents plus funds generated from operating cash flow.
During 1998, the Company's liquidity requirements were primarily
created and met by PILIC and PALHIC, along with the sale proceeds of MMC,
PALHIC, and NIA. During 1998 the primary sources of cash for Insurance
Operations were premiums, investment income and investment sales and maturities.
During 1998 the primary uses of cash for Insurance Operations were benefit
payments to insureds, operating costs including policy acquisition costs and
investment purchases. The primary sources of cash for HealthAxis were funds from
the issuance of debt and equity securities to outside parties and to PILIC. The
primary uses of cash for HealthAxis were operating costs and payments to AOL,
Lycos and CNet.
During 1999, the Company's liquidity requirements will be primarily
created and met by HealthAxis and PAMCO through the private placement of debt
and equity securities along with the sale of short and intermediate term
interest-bearing marketable securities in PILIC and, to a lesser degree,
individual life premiums, investment income and commissions and administrative
fees. The primary uses of cash for Insurance Operations are claim payments and
associated general expenses related to the 1998 claim run-off, which have been
established as claim reserves, and life benefit payments to insureds and life
operating costs. The primary uses of cash for HealthAxis are operating costs and
payments to AOL, Lycos, Snap and CNet.
Page 23 of 31 Pages
<PAGE>
Cash and investments carried at market value at June 30, 1999 amounted
to $38.4 million. This included $24.8 million of bonds issued by the U.S.
Government, government agencies, public utilities and other corporations, $1.1
million invested in policy loans and other invested assets and $12.5 million in
cash and cash equivalents. Bonds are investment grade securities with fixed
incomes ranging in maturity from one to 30 years. The gross average yield on
fixed income bonds as of June 30, 1999 and December 31, 1998 was 6.3%. All bonds
are considered to be "available for sale". The Company and its subsidiaries do
not invest in high-yield debt instruments, defined as securities below
investment grade with interest rates or yields significantly above market rates
nor does the Company invest in derivatives or hedging in financial instruments.
Net cash used in operating activities of $36.3 million in 1999 was
primarily the result of claim payments to policyholders, in particular health
claim payments related to the 1998 claim run-off of group medical business,
interactive sales and marketing expenses related to HealthAxis and other
operating expenses.
During 1999 HealthAxis made the final payment of $1.5 million to AOL
under the initial term of Second Amendment to the Amended and Restated
Interactive Marketing Agreement with AOL. Additionally, HealthAxis paid $1.1
million to other Internet partners. Payments to Internet partners are included
in prepaid interactive marketing expense.
Amounts due from reinsurer decreased primarily due to the collection of
amounts outstanding as of December 31, 1998 and an increase in the allowance for
uncollectable amounts.
In connection with the Company's outsourcing with HPS, the Company
received premiums, net of commissions, HPS fees and certain out of pocket
expenses monthly on or before the 15th of following month. The $6.8 million
change in amounts due from third party administrator represented December 1998's
net cash settlement collected from HPS in January 1999.
Future policy benefits and claims of $15.1 million related primarily to
the payment of claims incurred prior to 1999 for the Company's group medical and
group life business. Premiums, claims and expenses incurred on or after January
1, 1999 are 100% ceded to RCH, but the Company retains the liability to pay the
claims incurred prior to 1999.
Non-cash repayment of notes payable represents $1.5 million of
consideration for the Company's sale of MMC Common Stock and for HPS' exercise
of its warrant obtained in 1998 in connection with the HPS E-Commerce Agreement
to purchase 100,000 shares of PAMCO Common Stock for $900 as described in Note L
of the Notes to Financial Statements. Non cash issuance of warrants relates to
HealthAxis as described in Notes E and H of the Notes to Financial Statements.
Page 24 of 31 Pages
<PAGE>
The statutory capital and surplus of PILIC was $3.7 million at June 30,
1999, which is $3.3 million below Company Action Level Risk Based Capital
("RBC") and $0.2 million above Authorized Control Level RBC as calculated at
December 31, 1998. The statutory capital and surplus of PILIC, was $4.8 million
at December 31, 1998. At December 31, 1998, PILIC calculated its RBC utilizing a
formula required by the National Association of Insurance Commissioners. The
results of this computation indicate that PILIC's adjusted capital of $5.3
million exceeded Regulatory Action Level but was below Company Action Level as
of December 31, 1998. The RBC formula estimates RBC based on a variety of
historical data including 1998 net earned premium. Accordingly, PILIC's year end
1998 RBC calculation included approximately $4.8 million of RBC related to
PILIC's one life group health and group life business 100% ceded to RCH
effective January 1, 1999. PILIC's 1999 RBC calculation, once calculated for
1999, will be based on 1999 net written premium excluding the business 100%
ceded to RCH. In concept, Risk Based Capital standards are designed to measure
the acceptable amounts of capital an insurer should have based on inherent and
specific risks of the insurers business. This formula is a primary measurement
as to the adequacy of total capital and surplus of life insurance companies.
Since PILIC failed to meet its RBC requirement as of December 31, 1998 it is
subject to regulatory action. Several Departments of Insurance have requested
that PILIC submit a Risk Based Capital Plan ("RBC Plan") because PILIC's
adjusted capital of $5.3 million was below Company Action Level as of December
31, 1998. The goal of PILIC's RBC Plan is for PILIC's adjusted statutory capital
and surplus level to exceed PILIC's Company Action Level RBC. PILIC has
submitted its RBC Plan and is working on refining and executing its RBC Plan to
achieve its objective including the potential reinsurance of PILIC's life
insurance inforce and the sale of PILIC as described in Note J of the Notes to
Financial Statements. Insurers failing to meet their RBC requirement may be
subject to scrutiny by its domiciled insurance department and other insurance
departments, which the insurer does business in, and, ultimately, rehabilitation
or liquidation of PILIC.
During 1999 PILIC did not meet certain minimum capital and surplus
requirements in the states of Florida and Virginia and has been directed to
cease writing new business in those states. Existing inforce policies in those
states are not affected. The Company does not anticipate that this will have a
material impact on the Company in light of the Company's plans to sell PILIC.
Administrative rules and legal restrictions of state insurance
departments presently prevent payment of dividends by PILIC to PAMCO without
regulatory approval. Payment of dividends paid by HealthAxis to PAMCO is subject
to restrictions set for in the Certificate of Designation related to HealthAxis
Series A, B, C and D Convertible Preferred Stock. PAMCO and PILIC are also
restricted from paying dividends as described in Note K of the Notes to
Financial Statements. PAMCO, PILIC and HealthAxis do not anticipate paying cash
dividends on Common Stock or on any class of HealthAxis preferred stock in the
foreseeable future.
Impact of Inflation
Inflation increases the need for insurance. Many policyholders who once
had adequate insurance programs increase their life insurance coverage to
provide the same relative financial benefits and protection. The effect of
inflation on medical costs leads to accident and health policies with higher
benefits. Thus, inflation has increased the need for life and accident and
health products.
Page 25 of 31 Pages
<PAGE>
Higher interest rates, which have traditionally accompanied inflation,
affect the Company's investment operation. The market value of the Company's
fixed rate long-term investments decreases as interest rates increase.
Inflation has significantly increased the cost of health care. The
adequacy of premium rates in relation to the level of health claims is
constantly monitored and, where appropriate, premium rates on such policies,
when appropriate, are increased as policy benefits increase. Failure to make
such increases commensurate with health care cost increases may result in a loss
from health Insurance Operations.
The Company's pre-need products include periodic adjustments to the
face amount of the policy for increases in the consumer price index.
Expenditures and Commitments
PAMCO anticipates the need to raise capital in 1999 through private
offerings of either debt or equity securities which will be used for working
capital and other general corporate purposes including approximately $8.3
million to purchase shares of HealthAxis Common Stock as described in Note I of
the Notes to Financial Statements and $14.7 million to sell PILIC as described
in Note J of the Notes to Financial Statements. No assurances can be given with
regard to the success, terms or timing of the Company's efforts in obtaining
such funding. In the event that PAMCO is unable to obtain funding and pay $7,040
by October 31, 1999 to HPS it will be in breach of its Stock Purchase Agreement
with HPS and will be unable to sell its Insurance Operations or maintain
sufficient statutory capital and surplus levels in PILIC needed to avoid
regulatory intervention which may include oversight and, ultimately,
rehabilitation or liquidation of PILIC.
During the six months ended June 30, 1999, HealthAxis completed two
private placement offerings which provided approximately $15.0 million of cash
and in July 1999, completed an additional private placement which provided an
additional $4.0 million of cash described in Notes F, H and M of the Notes to
Financial Statements. The net proceeds of approximately $18.3 million are
anticipated to be used to fund amounts due under the Company's distribution
agreements with AOL, Lycos, CNet and Snap through the end of fiscal 1999, and
the balance is intended to be used by HealthAxis for its working capital and
other general purposes. The Company believes that the net proceeds together with
its current cash and cash equivalents will be sufficient to fund HealthAxis'
current operations and amounts due to AOL, Lycos, CNet and Snap during 1999.
However, the Company believes that subsequent equity or debt financings will be
necessary to enable HealthAxis to continue to fund operations and implement its
current business strategies.
The Company has no material commitments for capital expenditures at
June 30, 1999 but expects such expenditures to total approximately $2.2 million
in 1999. Such expenditures will primarily be for equipment, software, furniture
and leasehold improvements. The Company has purchased $1.2 million of property
and equipment during the six months ending June 30, 1999.
Page 26 of 31 Pages
<PAGE>
HealthAxis has entered into an Interactive Marketing Agreement with AOL
and promotional agreements with CNet, Snap and Lycos. In connection with these
agreements, the Company has paid $14.6 million in cash and warrants as of June
30, 1999 and is required to pay additional amounts as described in Notes F, G, H
and AA to the Company's Consolidated Financial Statements for the year ended
December 31, 1998.
The Company does not anticipate paying cash dividends on Common Stock
or on any series or class of HealthAxis stock in the foreseeable future.
Year 2000 compliance
Year 2000 issues are the result of computer programs being written
using two digits rather than four to define the applicable year. In other words,
date-sensitive software may recognize a date using "00" as the year 1900 rather
than the Year 2000. This could result in system failures or miscalculations
causing disruptions in operations, including, among other things, a temporary
inability to process transactions, send invoices, or engage in similar normal
business activities.
The Company utilizes various computer software programs, operating
systems and vendors whose software programs and communication links ("Computer
Systems") are used in the Company's Insurance Operations and HealthAxis. For the
Company's Insurance Operations these Computer Systems include health insurance
administration provided by HPS, life insurance administration, health claims
discount repricing provided by First Health Group along with financial
accounting and actuarial systems. For HealthAxis, these Computer Systems include
the www.healthaxis.com web site, links to AOL along with the AOL online network,
links to Lycos, CNET, Snap, Carrier Partners, HPS, First Health Group, along
with HealthAxis' data warehouse. To the extent that the Company's Computer
Systems contain source codes that are unable to appropriately interpret the Year
2000 then some level of modification, or even replacement of such applications
may be necessary. The result of these Year 2000 issues may, if not corrected,
have a significant negative impact on the Company's business.
HealthAxis has established a task force to assess its systems to
determine whether they correctly define the Year 2000 and to determine the
extent to which the systems of its suppliers, Internet partners, Carrier
Partners and other business partners (insofar as they are material to
HealthAxis' business) are subject to the Year 2000 issue. The Company
anticipates this assessment will be completed in August 1999. HealthAxis is
currently unable to predict the extent to which the Year 2000 issue will affect
its operations or the extent to which it would be vulnerable to Year 2000 issues
affecting its business partners failure to remediate any Year 2000 issues on a
timely basis. The failure of a business partner to convert systems on a timely
basis, in a manner that is compatible with HealthAxis' systems, could have a
material adverse effect on the Company. HealthAxis does not have a contingency
plan in place in the event that it or any third party in which it engages in
business is not Year 2000 compliant. In addition, policy purchases are made with
credit cards, and HealthAxis' operations may be materially adversely affected to
the extent its customers are unable to use credit cards due to the Year 2000
issues that are not rectified by credit card vendors.
To date, the Company has eliminated its health administration system by
outsourcing health administration and claims processing to HPS effective
February 1998 and assigning responsibility of the oversight of HPS' health
administration and claims processing along with the Company's former health
agent and underwriting computer systems to CRLC effective December 31, 1998.
Page 27 of 31 Pages
<PAGE>
To date, the Company has experienced very few Year 2000 problems with
those problems centering on life administration processing. The cost of
programming changes as of June 30, 1999 was less than $132. As described in Note
J of the Notes to Financial Statements, the Company is in the process of
pursuing the reinsurance of its life insurance inforce and the sale of PILIC
prior to year-end. If the Company does not sell its life inforce business it
will need to pursue alternatives including the modification of its life
administration system at a cost yet to be estimated or the effective replacement
of the system by outsourcing the life system at an estimated incremental annual
cost of approximately $300 per year and a one time conversion cost of
approximately $300. There are also business and financial risks associated with
the Company's Year 2000 exposure relating to its life administration system in
that the Company may not be able to transfer the administration of the business
to a Y2K compliant system prior to encountering Y2K problems.
In the event that the Computer Systems of the Company or any of the
Company's business partners fail or exhibit significant problems as a result of
Year 2000 processing the Company's service to its customers could be disrupted
for a significant amount of time and result in significant lost income to the
Company.
There are risks associated with the Company's Year 2000 exposure
relating to some external vendors with whom the Company depends on material
sales and service processing. Because the Company does not control these vendors
or their resources, the Company can provide no assurance that such vendors will
complete their respective Year 2000 solutions in time for the Company to fully
test system interfaces with them. Although the Company is coordinating its
efforts with vendors to minimize this impact of Year 2000 issues, the Company is
currently unable to predict the extent to which Year 2000 issues will affect its
operations, or the extent to which it would be vulnerable to the failure of its
business partners or other, to remediate any Year 2000 issues on a timely basis.
The Company has begun the process of developing a contingency plan to
address possible Year 2000 risks to its Computer Systems. There can be no
assurance that the Company will successfully implement its contingency plan or
make all of its systems Year 2000 compliant. The Company does not have a
contingency plan in place in the event any third party in which it engages in
business is not Year 2000 compliant.
Recent Sales of Unregistered Securities
The issuance of securities described below were made pursuant to
exemptions from registration pursuant to Section 4(2) of the Securities Act of
1933, as amended, in reliance upon the fact that such sales did not involve a
public offering. As a result, such securities are subject to restrictions on
transfer. During the six months ended June 30, 1999, the Company entered into
the following sales of unregistered securities of which all dollar amounts are
in whole dollars:
In March 1999 HealthAxis entered into an Amended and Restated Carrier
Partner Agreement with UICI, pursuant to which HealthAxis issued a warrant to
UICI to purchase 150,000 shares of HealthAxis common stock at $4.40 per share,
with a five-year term. See in Note E to the Consolidated Financial Statements
included herein for a further explanation.
Page 28 of 31 Pages
<PAGE>
In March 1999 HealthAxis completed a private placement of 1,526,412
shares of HealthAxis Series C Cumulative Convertible Preferred Stock to a group
of accredited investors at $5.77 per share for an aggregate purchase price of
$8,807,397, less issuance cost of $683,501. See Note H to the Consolidated
Financial Statements included herein for a further explanation.
In May 1999 HealthAxis entered into a Strategic Alliance Agreement with
First Health, pursuant to which HealthAxis issued a warrant to First Health for
50,000 shares of HealthAxis common stock at $20.00 per share, with a three-year
term. See in Note E to the Consolidated Financial Statements included herein for
a further explanation.
In May 1999 HealthAxis completed a private placement of 516,051 shares
of HealthAxis common stock to a group of accredited investors at $12.00 per
share for an aggregate purchase price of $6,193,000, less issuance cost of
$2,000. See in Note F to the Consolidated Financial Statements included herein
for a further explanation.
In June 1999 HealthAxis issued a warrant to ING Barring, Inc. ("ING
Barring") for 63,000 shares of HealthAxis common stock at $5.77 per share, with
a five-year term commencing on March 30, 1999. This warrant was issued in
settlement of its obligations pursuant to the engagement letter dated December
22, 1998 between ING Barring and HealthAxis and in connection with the
settlement agreement and mutual release dated June 16, 1999.
No commissions have been paid in connection with the above sales,
except with regard to the HealthAxis Series C Preferred Stock. In connection
therewith a placement fee of $300,000 was paid and warrants as described in the
previous paragraph were issued.
Page 29 of 31 Pages
<PAGE>
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
Not applicable.
Item 2. Change in Securities.
Not applicable.
Item 3. Defaults Upon Senior Securities.
Not applicable.
Item 4. Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 5. Other Information.
Not applicable.
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibits: Not applicable.
(b) Reports on Form 8-K:
(1) Item 5 regarding a settlement agreement between the
Company, its two subsidiaries, Provident Indemnity Life
Insurance Company and HealthAxis.com, Inc., HealthPlan
Services, Inc., HealthPlan Services Corporation and
Montgomery Management Corporation, filed on June 29,
1999.
(2) Item 5 regarding the Company's subsidiary,
HealthAxis.com, Inc. completed the private equity
placement of $4 million of HealthAxis Series D
Preferred Stock filed on July 26, 1999.
(c) Reports on Form 8-K/A:
(1) Additional Exhibits filed on May 14, 1999 not included
with original Form 8-K filing dated April 30, 1999.
(2) Clarification amendment filed June 22, 1999 of the
original filing dated May 13, 1999.
Page 30 of 31 Pages
<PAGE>
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Provident American Corporation
By: /s/ Alvin H. Clemens
-----------------------------------------------------
Alvin H. Clemens, Chairman of the Board of Directors,
President and Chief Executive Officer
By: /s/ Anthony R. Verdi
-----------------------------------------------------
Anthony R. Verdi, Chief Operating Officer
By: /s/ Francis L. Gillan III
-----------------------------------------------------
Francis L. Gillan III, Chief Financial Officer and
Treasurer
Date: August 16, 1999
Page 31 of 31 Pages
<PAGE>
EXHIBIT 11
PROVIDENT AMERICAN CORPORATION
COMPUTATION OF EARNINGS (LOSS) PER SHARE
<TABLE>
<CAPTION>
(In thousands except per share data) Three Months Ended June 30 Six Months Ended June 30,
1999 1998 1999 1998
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Primary Earnings (Loss) Per Share
- ---------------------------------
NET INCOME (LOSS) APPLICABLE TO COMMON STOCK: ($10,539) ($2,381) $(13,440) $ 254 $
- ------------------------------------------------------------------------------------------------------------------------------------
WEIGHTED AVERAGE SHARES:
Common stock 12,039 11,990 11,797 11,699
Common stock equivalents applicable to stock options and warrants * *
- ------------------------------------------------------------------------------------------------------------------------------------
Total 12,039 11,990 11,797 11,699
- ------------------------------------------------------------------------------------------------------------------------------------
PRIMARY EARNINGS (LOSS) PER SHARE: (0.88) $ (0.20) $ (1.14) $ 0.02 $
- ------------------------------------------------------------------------------------------------------------------------------------
Fully Diluted Earnings (Loss) Per Share
- ---------------------------------------
NET INCOME (LOSS) APPLICABLE TO COMMON STOCK: (10,539) $ (2,381) $(13,440) $ 254 $
- ------------------------------------------------------------------------------------------------------------------------------------
WEIGHTED AVERAGE SHARES:
Common stock 12,039 11,990 11,797 11,699
Common stock equivalents applicable to stock options and warrants * * 74
- ------------------------------------------------------------------------------------------------------------------------------------
Total 12,039 11,990 11,797 11,773
- ------------------------------------------------------------------------------------------------------------------------------------
FULLY DILUTED EARNINGS (LOSS) PER SHARE: (0.88) $ (0.20) $ (1.14) $ 0.02 $
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
* Anti-dilutive; therefore effects have been excluded.
<TABLE> <S> <C>
<ARTICLE> 7
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> JUN-30-1999
<DEBT-HELD-FOR-SALE> 24,790
<DEBT-CARRYING-VALUE> 0
<DEBT-MARKET-VALUE> 0
<EQUITIES> 0
<MORTGAGE> 276
<REAL-ESTATE> 0
<TOTAL-INVEST> 25,858
<CASH> 12,534
<RECOVER-REINSURE> 36,687
<DEFERRED-ACQUISITION> 2,205
<TOTAL-ASSETS> 100,523
<POLICY-LOSSES> 43,009
<UNEARNED-PREMIUMS> 0
<POLICY-OTHER> 27,113
<POLICY-HOLDER-FUNDS> 4,467
<NOTES-PAYABLE> 0
0
550
<COMMON> 1,220
<OTHER-SE> 129
<TOTAL-LIABILITY-AND-EQUITY> 100,523
4,054
<INVESTMENT-INCOME> 1,613
<INVESTMENT-GAINS> 0
<OTHER-INCOME> 517
<BENEFITS> 5,699
<UNDERWRITING-AMORTIZATION> 252
<UNDERWRITING-OTHER> 6,749
<INCOME-PRETAX> (15,077)
<INCOME-TAX> 18
<INCOME-CONTINUING> (15,095)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (13,371)
<EPS-BASIC> (1.14)
<EPS-DILUTED> (1.14)
<RESERVE-OPEN> 0
<PROVISION-CURRENT> 0
<PROVISION-PRIOR> 0
<PAYMENTS-CURRENT> 0
<PAYMENTS-PRIOR> 0
<RESERVE-CLOSE> 0
<CUMULATIVE-DEFICIENCY> 0
</TABLE>
